Overview

A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)

Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
A study to evaluate MK0476 and Fluticasone to control asthma in patients with mild persistent asthma.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Fluticasone
Montelukast
Xhance